Synapse (Cursor for Life Science Teams)

Drug valuation is paralyzed by disconnected teams using fragile, static spreadsheets that cannot keep pace with the complexity of drug development. This fragmentation traps Clinical, Commercial, and Strategy insights in opaque formulas and version control errors, leading to high-stakes decisions based on stale data. Synapse solves this by unifying stakeholders in a single workspace where AI agents instantly translate natural language conversations across functions into live, executable code and market models, creating a transparent, real-time single source of truth for key assets.